site stats

Gronberg bh et al. j clin oncol. 2009 27:3217

WebNov 4, 2016 · J Clin Oncol 27:3217-3224. © 2009 by American Society of Clinical Oncology INTRODUCTION Systemic therapies prolong survival and improve health-related quality … WebFeb 10, 2009 · Purpose: To evaluate single-agent activity of bevacizumab in patients with recurrent glioblastoma. Patients and methods: Patients with recurrent glioblastoma were treated with bevacizumab 10 mg/kg every 2 weeks. After tumor progression, patients were immediately treated with bevacizumab in combination with irinotecan 340 mg/m(2) or 125 …

Non-Small Cell Lung Cancer (NSCLC) Treatment Protocols

WebJun 1, 2024 · CA: A Cancer Journal for Clinicians publishes information about the prevention, early detection, and treatment of cancer, as well as nutrition, palliative care, survivorship, and additional topics of interest related to cancer care. WebGronberg BH, Bremnes RM, Flotten O, et al. Phase III study by the Norwegian lung cancer study group: pemetrexed plus carboplatin compared with gemcitabine plus carboplatin as first-line chemotherapy in advanced non-small-cell lung cancer. J Clin Oncol. 2009;27: 3217 – 3224. , , [Google Scholar] tring ott https://b2galliance.com

Post-study therapy as a source of confounding in survival analysis …

WebSep 20, 2009 · Vol. 27, No. 27, September 20, 2009 Editorials Phase I Drug Combination Trial Design: Walking the Tightrope Hamberg et al. pp. 4441–4443 Citation Full Text … WebNov 4, 2016 · Phase III Study by the Norwegian Lung Cancer Study Group: Pemetrexed ... ... group, ... WebMar 21, 2024 · J Clin Oncol. 2009;27(5):740–5. Article CAS PubMed Google Scholar Lai A, Tran A, Nghiemphu PL, Pope WB, Solis OE, Selch M, et al. Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme. J Clin Oncol. 2011;29(2):142–8. tringo table

Pemetrexed-Carboplatin Adjuvant Chemotherapy With or Without …

Category:Treatment Considerations for MGMT -Unmethylated …

Tags:Gronberg bh et al. j clin oncol. 2009 27:3217

Gronberg bh et al. j clin oncol. 2009 27:3217

Critical appraisal of pemetrexed in the treatment of NSCLC and ...

WebApr 20, 2009 · Purpose: Trastuzumab shows clinical activity in human epidermal growth factor receptor 2 (HER-2)-positive early and advanced breast cancer. In the German … WebMay 29, 2013 · Eight-two patients were enrolled on the trial between May 2008 and July 2011, comprising 56 (68.3%) males and 26 (31.7%) females with a median age of 58 …

Gronberg bh et al. j clin oncol. 2009 27:3217

Did you know?

WebDec 19, 2024 · Gronberg BH, Bremnes RM, Flotten O, et al. Phase III study by the Norwegian lung cancer study group: pemetrexed plus carboplatin compared with … WebJun 1, 2024 · Abstract. Glioblastoma is the most common malignant primary brain tumor. Overall, the prognosis for patients with this disease is poor, with a median survival of <2 …

WebMay 11, 2009 · Purpose To compare pemetrexed/carboplatin with a standard regimen as first-line therapy in advanced non–small-cell lung cancer NSCLC. Patients and Methods … WebOct 1, 2009 · Patients and methods: This is a phase III, multicenter, randomized (1:1), double-blind, placebo-controlled study. Patients with non-Hodgkin's lymphoma requiring …

WebApr 12, 2024 · Journal of Clinical Oncology (JCO) is a high-impact, peer-reviewed medical journal that publishes significant clinical oncology research along with editorials, … WebAug 20, 2013 · The haematological toxicities were comparable to other studies (Helbekkmo et al, 2007; Gronberg et al, 2009; Takigawa et al, 2011), but the number of hospital admissions in relation to side ...

WebDec 10, 2009 · Purpose: To review and update the European LeukemiaNet (ELN) recommendations for the management of chronic myeloid leukemia with imatinib and second-generation tyrosine kinase inhibitors (TKIs), including monitoring, response definition, and first- and second-line therapy. Methods: These recommendations are …

WebOct 1, 2009 · Purpose: Somatostatin analogs are indicated for symptom control in patients with gastroenteropancreatic neuroendocrine tumors (NETs). The ability of somatostatin analogs to control the growth of well-differentiated metastatic NETs is a matter of debate. We performed a placebo-controlled, double-blind, phase IIIB study in patients with well … tesla model 3 how long to chargeWebAug 1, 2009 · Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy J Clin Oncol. 2009 Aug 1;27 (22):3677 … tring picturesWebDec 7, 2010 · Gronberg BH, Bremnes RM, Flotten O, Amundsen T, Brunsvig PF, Hjelde HH, et al. Phase III study by the Norwegian lung cancer study group: pemetrexed plus … tesla model 3 leather steering wheelWebMar 25, 2011 · Gronberg BH, Bremnes RM, Flotten O, et al. Phase III study by the Norwegian lung cancer study group: pemetrexed plus carboplatin compared with … tesla model 3 lithium 12v batteryWebDec 1, 2009 · 10.1200/JCO.2009.23.2025 Abstract Purpose: To evaluate the risk of recurrence in women diagnosed with T1a and T1b, node-negative, human epidermal … tesla model 3 leasing prisWebJun 9, 2024 · Int J Radiat Oncol Biol Phys. 2009; 73: 1069-1076. Abstract; Full Text; ... Am J Clin Oncol. 2004; 27: 505-509. Crossref; PubMed; Scopus (29) Google Scholar; The analysis detected statistical heterogeneity (I 2 70%). ... Gronberg BH ; Ciuleanu T ; Flotten O ; et al. A placebo-controlled, randomized phase II study of maintenance enzastaurin ... tesla model 3 hitch bike rackWebJ Clin Oncol 2003; 21: ... Gronberg BH, Bremnes RM, Flotten O, et al. Phase III study by the Norwegian lung cancer study group: pemetrexed plus carboplatin compared with gemcitabine plus carboplatin as first-line chemotherapy in advanced non-small-cell lung cancer. J Clin Oncol 2009; 27: 3217 ... tring orthodontist